Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Videos
Webinars
Press Releases
Whitepapers
Advertising
Financial Results: Page 10
Qiagen sales, earnings climb in Q3
By
LabPulse.com staff writers
For the period (end-September 30), Qiagen expects to report net sales of $481.3 million, up 26% at both actual and constant exchange rates from the $382.7 million produced in the third quarter of 2019. Non-COVID-19 testing products declined at only a mid-single-digit rate compared with the same period a year ago.
October 12, 2020
Illumina's Q2 revenue drops 25%
By
LabPulse.com staff writers
The firm announced revenue decreased from $838 million in the second quarter of last year to $633 million in this year's second quarter because of pandemic-related disruption in customers' operations, Illumina said.
August 9, 2020
Siemens revenue falls 7% in third quarter
By
LabPulse.com staff writers
For the period (end-June 30), Siemens Healthineers posted revenues of 3.312 billion euros ($3.893 billion U.S.), down 7.2% compared with revenues of 3.569 billion ($4.196 billion) in the third quarter of 2019, and down 6.9% after adjusting for currency effects. The company's net income was 271 million euros ($318.6 million), down compared with 353 million euros ($414.9 million) in the corresponding quarter of 2019.
August 2, 2020
Siemens revenue falls 7% in third quarter
By
LabPulse.com staff writers
For the period (end-June 30), Siemens Healthineers posted revenues of 3.312 billion euros ($3.893 billion U.S.), down 7.2% compared with revenues of 3.569 billion ($4.196 billion) in the third quarter of 2019, and down 6.9% after adjusting for currency effects. The company's net income was 271 million euros ($318.6 million), down compared with 353 million euros ($414.9 million) in the corresponding quarter of 2019.
August 2, 2020
Bio-Rad's Q2 revenue drops
By
LabPulse.com staff writers
Sales dropped 6.2% to $536.9 million compared with $572.6 million for the second quarter of 2019. In particular, revenues in the company's clinical diagnostics segment decreased by 20.7%.
July 30, 2020
COVID-19 spurs Q2 sales boom at Quidel
By
LabPulse.com staff writers
Q2 revenue increased 86% from $108.3 million in 2019 to $201.8 million with sales of its COVID-19 tests accounting for $109 million of the growth. Specifically, rapid immunoassay product revenue increased 270% in the company's second quarter to $80.6 million, primarily due to $56.3 million in revenue for Quidel's Sofia severe acute respiratory syndrome (SARS) Antigen test.
July 30, 2020
Molecular diagnostics sales surge in Hologic's Q3
By
LabPulse.com staff writers
For the quarter (end-June 27), Hologic reported revenue of $822.9 million, compared with $852.4 million in the same quarter of 2019. The 3.5% decline was due to the loss of sales from Hologic's Cynosure division, which it sold in January.
July 29, 2020
Molecular diagnostics sales surge in Hologic's Q3
By
LabPulse.com staff writers
For the quarter (end-June 27), Hologic reported revenue of $822.9 million, compared with $852.4 million in the same quarter of 2019. The 3.5% decline was due to the loss of sales from Hologic's Cynosure division, which it sold in January.
July 29, 2020
Abbott reports dip in sales and income in Q2
By
LabPulse.com staff writers
The company reported sales dropped 8.2% to $7.3 billion in the second quarter of 2020, compared to $7.97 billion during the same period in 2019.
July 21, 2020
Quest overall testing volume, revenue decline
By
LabPulse.com staff writers
For the quarter (end-June 30), the company expected reported revenue to be roughly $1.83 billion, a 6% decline compared to the same quarter of 2019. The company attributed the decline to an 18% drop in overall testing volume compared with 2019.
July 12, 2020
PerkinElmer Q1 revenues edge up, profit edges down
By
LabPulse.com staff writers
For the period, PerkinElmer recorded revenue of $652.4 million, up 1% from revenue of $648.7 million in the first quarter of 2019. The company's net income fell slightly, to $33.7 million, compared with $35.4 million in the corresponding quarter the year before.
May 6, 2020
BD revenues edge up for 2nd quarter
By
LabPulse.com staff writers
For the quarter, BD reported sales of $4.253 billion, up 1.4% from $4.195 billion in the same period of 2019. The company's net income was $183 million, compared with $20 million in the corresponding quarter of 2019.
May 6, 2020
Previous Page
Page 10 of 12
Next Page